Escudero-Castellanos, Alondra; Kurth, Jens; Imlimthan, Surachet; Menéndez, Elena; Pilatis, Eirinaios; Moon, Euy Sung; Läppchen, Tilman; Rathke, Hendrik; Schwarzenböck, Sarah M; Krause, Bernd J; Rösch, Frank; Rominger, Axel; Gourni, Eleni (2023). Translational assessment of a DATA-functionalized FAP inhibitor with facile 68Ga-labeling at room temperature. European journal of nuclear medicine and molecular imaging, 50(11), pp. 3202-3213. Springer 10.1007/s00259-023-06285-2
|
Text
s00259-023-06285-2.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview |
PURPOSE
The present study aims at evaluating the preclinical and the clinical performance of [68Ga]Ga-DATA5m.SA.FAPi, which has the advantage to be labeled with gallium-68 at room temperature.
METHODS
[68Ga]Ga-DATA5m.SA.FAPi was assessed in vitro on FAP-expressing stromal cells, followed by biodistribution and in vivo imaging on prostate and glioblastoma xenografts. Moreover, the clinical assessment of [68Ga]Ga-DATA5m.SA.FAPi was conducted on six patients with prostate cancer, aiming on investigating, biodistribution, biokinetics, and determining tumor uptake.
RESULTS
[68Ga]Ga-DATA5m.SA.FAPi is quantitatively prepared in an instant kit-type version at room temperature. It demonstrated high stability in human serum, affinity for FAP in the low nanomolar range, and high internalization rate when associated with CAFs. Biodistribution and PET studies in prostate and glioblastoma xenografts revealed high and specific tumor uptake. Elimination of the radiotracer mainly occurred through the urinary tract. The clinical data are in accordance with the preclinical data concerning the organ receiving the highest absorbed dose (urinary bladder wall, heart wall, spleen, and kidneys). Different to the small-animal data, uptake of [68Ga]Ga-DATA5m.SA.FAPi in tumor lesions is rapid and stable and tumor-to-organ and tumor-to-blood uptake ratios are high.
CONCLUSION
The radiochemical, preclinical, and clinical data obtained in this study strongly support further development of [68Ga]Ga-DATA5m.SA.FAPi as a diagnostic tool for FAP imaging.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine |
UniBE Contributor: |
Imlimthan, Surachet, Pilatis, Eirinaios, Läppchen, Tilman, Rathke, Hendrik Gabriel, Rominger, Axel Oliver |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1619-7089 |
Publisher: |
Springer |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
08 Jun 2023 11:55 |
Last Modified: |
30 Sep 2023 00:13 |
Publisher DOI: |
10.1007/s00259-023-06285-2 |
PubMed ID: |
37284857 |
Uncontrolled Keywords: |
CAF FAP inhibitors PET imaging Tumor stroma |
BORIS DOI: |
10.48350/183239 |
URI: |
https://boris.unibe.ch/id/eprint/183239 |
Actions (login required)
 |
Edit item |